These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6128921)

  • 1. Effect of a consultant pharmacist on medication use in an institution for the mentally retarded.
    Berchou RC
    Am J Hosp Pharm; 1982 Oct; 39(10):1671-4. PubMed ID: 6128921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist impact on drug use in an institution for the mentally retarded.
    Ellenor GL; Frisk PA
    Am J Hosp Pharm; 1977 Jun; 34(6):604-8. PubMed ID: 879182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug use by mentally handicapped persons in institutions and family-replacing residential facilities].
    van Schrojenstein Lantman-de Valk HM; Kessels AG; Haveman MJ; Maaskant MA; Urlings HF; van den Akker M
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1083-8. PubMed ID: 7783802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of federal indicators in nursing-home drug-regimen review.
    Shannon RC; De Muth JE
    Am J Hosp Pharm; 1984 May; 41(5):912-6. PubMed ID: 6731451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consulting pharmacist services: evaluation by long-term care facility administrators.
    Evens RP; McCulloch-Turner P
    Hosp Formul; 1986 Feb; 21(2):220-8. PubMed ID: 10275577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug administration and control in a large mental retardation facility.
    Delk J
    Hosp Pharm; 1984 Mar; 19(3):177-9, 184-5. PubMed ID: 10265847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacy services in an intermediate care facility for the mentally retarded.
    McKee JR
    Hosp Pharm; 1994 Mar; 29(3):228-30, 233-4, 237. PubMed ID: 10132698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacist-managed medication review in a managed care system.
    Borgsdorf LR; Miano JS; Knapp KK
    Am J Hosp Pharm; 1994 Mar; 51(6):772-7. PubMed ID: 8010315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some studies in an institution for the mentally retarded.
    Sewell J; Werry JS
    N Z Med J; 1976 Oct; 84(574):317-9. PubMed ID: 14320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a psychotropic drug review service in a mental retardation facility.
    Marcoux AW
    Hosp Pharm; 1985 Nov; 20(11):827-31. PubMed ID: 10274172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of medication records and use of pharmacy resources in community residential care facilities.
    Gray SL; Odegard PS; Sales AE; Young HM; Sullivan JH; Hedrick SC
    Ann Pharmacother; 2006 May; 40(5):894-9. PubMed ID: 16638918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of comprehensive pharmaceutical services on drug use in long-term care facilities.
    Strandberg LR; Dawson GW; Mathieson D; Rawlings J; Clark BG
    Am J Hosp Pharm; 1980 Jan; 37(1):92-4. PubMed ID: 6987865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.